CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$31.49
+0.01 (+0.03%)
Analyst Consensus
Sell
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+59.2% upside
Low Target
$36.48
Average Target
$50.13
High Target
$69.47
Current Price
$31.49
Current
$31.49
$31.49
Target
$50.13
$50.13
$36.48
$50.13 avg
$69.47
Scenario Analysis
Bear Case
$36.48
15.8%
Low target
Base Case
$50.13
+59.2%
Avg target
Bull Case
$69.47
+120.6%
High target
Risk/Reward
7.6x
Highly favorable
Price in Context
52-Week High
$32.56
-3.3% from high
52-Week Low
$19.05
+65.3% from low
50-Day SMA
$23.76
+32.5% vs SMA
200-Day SMA
$22.30
+41.2% vs SMA
RSI (14)
48.5
Neutral
Target vs 52W High
$50.13
+54.0% vs high
Next Earnings Report
Aug 12, 2026
4d
until earnings
EPS Est: $0.49
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.4% |
| AMGN | Hold | 43 | 49% | $190.87 | -52.7% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +179.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -46.0% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |